ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 26 filers reported holding ARGOS THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $328,000 | -0.6% | 66,859 | +0.6% | 0.00% | – |
Q3 2016 | $330,000 | +35.8% | 66,488 | +68.0% | 0.00% | – |
Q2 2016 | $243,000 | +2109.1% | 39,567 | +2162.3% | 0.00% | – |
Q1 2016 | $11,000 | +175.0% | 1,749 | 0.0% | 0.00% | – |
Q4 2015 | $4,000 | -50.0% | 1,749 | +10.5% | 0.00% | – |
Q3 2015 | $8,000 | -27.3% | 1,583 | 0.0% | 0.00% | – |
Q2 2015 | $11,000 | +57.1% | 1,583 | +110.5% | 0.00% | – |
Q1 2015 | $7,000 | -12.5% | 752 | 0.0% | 0.00% | – |
Q4 2014 | $8,000 | 0.0% | 752 | 0.0% | 0.00% | – |
Q3 2014 | $8,000 | +33.3% | 752 | 0.0% | 0.00% | – |
Q2 2014 | $6,000 | -93.6% | 752 | -92.0% | 0.00% | – |
Q1 2014 | $94,000 | – | 9,435 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pharmstandard International S.A. | 13,242,279 | $4,808,000 | 16.67% |
Pharmstandard International S.A. | 5,120,604 | $1,859,000 | 6.44% |
SANDERS MORRIS HARRIS LLC | 141,212 | $52,000 | 0.02% |
ELEMENT CAPITAL MANAGEMENT LLC | 82,808 | $30,000 | 0.01% |
WEDBUSH SECURITIES INC | 89,500 | $32,000 | 0.00% |
Alyeska Investment Group, L.P. | 200,000 | $73,000 | 0.00% |
LMR Partners LLP | 45,017 | $16,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 129,046 | $46,000 | 0.00% |
STATE STREET CORP | 11,900 | $4,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 193,294 | $70,000 | 0.00% |